arrow
A

Anish Bhuva

university college london
H指数:30
被引数:4,205

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prevalence and determinants of asymmetric septal hypertrophy (ASH) in diseases of left ventricular hypertrophy (LVH)

左心室肥厚(LVH)疾病中非对称室间隔肥厚(ASH)的患病率及其影响因素

2026-08-030
OAAI
Reappraising cardiac function with myocardial contraction fraction: normal values, disease detection, and prognostication

Kurdi, H.; Thornton, G.; Shiwani, H.; Artico, J.; Abiodun, A.; Castelletti, S.; Rosmini, S.; Nordin, S.; Augusto, J.; Kozor, R.; et al. 重新评估心脏功能:心肌收缩分数的临床应用价值——正常值、疾病检测与预后判断。Eur. Heart J. Cardiovasc. Imaging 2026, 27, 803–816. [Google Scholar] [CrossRef]

2026-04-010
PRE
The Impact of Bariatric Surgery on Coronary Microvascular Function Assessed Using Automated Quantitative Perfusion CMR
2024-11-011
PRE
Prognostic utility and characterization of left ventricular hypertrophy using global thickness
2023-12-202
OAAI
The Relationship of Pericardial Fat With Metabolic Change and Myocardial Remodelling Following Bariatric Surgery
2023-11-070
PRE
[11C]metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trial
2023-01-1650
OAAI
Automated In-Line Artificial Intelligence Measured Global Longitudinal Shortening and Mitral Annular Plane Systolic Excursion: Reproducibility and Prognostic Significance
2022-02-1516
OAAI
Precision measurement of cardiac structure and function in cardiovascular magnetic resonance using machine learning
2022-01-0150
OAAI
Maximal Wall Thickness Measurement in Hypertrophic Cardiomyopathy Biomarker Variability and its Impact on Clinical Care
2021-11-0122
OAAI
Prognostic Value of Pulmonary Transit Time and Pulmonary Blood Volume Estimation Using Myocardial Perfusion CMR

使用心肌灌注CMR估算肺通过时间和肺血容量的预后价值

2021-11-0125
OAAI
Prospective Case-Control Study of Cardiovascular Abnormalities 6 Months Following Mild COVID-19 in Healthcare Workers

医务人员轻度新型冠状病毒肺炎后6个月心血管异常的前瞻性病例对照研究

2021-11-01113
OAAI
Evidence to support magnetic resonance conditional labelling of all pacemaker and defibrillator leads in patients with cardiac implantable electronic devices
2021-08-2631
OAAI